GLP-1 Receptor Agonist
  1. Home
  2. Wegovy
  3. GLP-1 Receptor Agonist

GLP-1 Receptor Agonist

GLP-1 Receptor Agonist is a prescription semaglutide therapy used for chronic weight management in adults and eligible adolescents when combined with a reduced-calorie diet and increased physical activity. It is supplied as a sterile pre-filled injection pen for convenient once-weekly subcutaneous administration. The long-acting formulation helps regulate appetite while providing accurate, reliable, and consistent dose delivery.

BUY NOW

Category

GLP-1 Receptor Agonist contains semaglutide, which mimics the naturally occurring glucagon-like peptide-1 (GLP-1) hormone to reduce appetite, increase satiety, slow gastric emptying, and decrease overall calorie intake. The sterile pre-filled injection pen is engineered for precise once-weekly subcutaneous administration and is available in multiple dosage strengths to support gradual dose escalation according to the prescribed treatment plan. Manufactured under stringent pharmaceutical quality standards, the ready-to-use injection pen delivers dependable clinical performance while ensuring convenient and accurate medication delivery. GLP-1 Receptor Agonist should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name GLP-1 Receptor Agonist
Active Ingredient Semaglutide
Dosage Form Sterile Pre-filled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

GLP-1 Receptor Agonist, Wegovy Injection, Semaglutide GLP-1 Therapy, Weekly Semaglutide Injection, GLP-1 Weight Management Injection, Injectable Semaglutide, Weight Loss Injection Pen